|
IPW expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.58990051626995E-10 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.20399998041421E-09 |
| Normal-vs-Stage2 |
5.297600E-03 |
| Normal-vs-Stage3 |
1.99817939972036E-12 |
| Normal-vs-Stage4 |
4.48640000039191E-07 |
| Stage1-vs-Stage2 |
4.371000E-01 |
| Stage1-vs-Stage3 |
3.080300E-02 |
| Stage1-vs-Stage4 |
5.226600E-01 |
| Stage2-vs-Stage3 |
7.231500E-02 |
| Stage2-vs-Stage4 |
2.898800E-01 |
| Stage3-vs-Stage4 |
3.567000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.9106050902783E-11 |
| Normal-vs-AfricanAmerican |
1.175090E-03 |
| Normal-vs-Asian |
1.682340E-02 |
| Caucasian-vs-AfricanAmerican |
3.711700E-02 |
| Caucasian-vs-Asian |
9.938600E-01 |
| AfricanAmerican-vs-Asian |
3.895000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.37799999083899E-09 |
| Normal-vs-Female |
6.73070044143742E-10 |
| Male-vs-Female |
2.329400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.812499999998E-05 |
| Normal-vs-Age(41-60Yrs) |
2.60139998431441E-09 |
| Normal-vs-Age(61-80Yrs) |
1.34409999796858E-08 |
| Normal-vs-Age(81-100Yrs) |
4.209700E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.106400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.156000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.633200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.019200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.164400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.176600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.445600E-02 |
| Normal-vs-Grade 2 |
2.35049999997017E-06 |
| Normal-vs-Grade 3 |
7.7180994928483E-10 |
| Normal-vs-Grade 4 |
1.73128178460047E-12 |
| Grade 1-vs-Grade 2 |
9.186200E-01 |
| Grade 1-vs-Grade 3 |
4.404800E-01 |
| Grade 1-vs-Grade 4 |
2.083700E-02 |
| Grade 2-vs-Grade 3 |
7.221800E-02 |
| Grade 2-vs-Grade 4 |
2.31679999999068E-05 |
| Grade 3-vs-Grade 4 |
1.898720E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.60649999969564E-07 |
| Normal-vs-ccB subtype |
3.23320037409758E-10 |
| ccA subtype-vs-ccB subtype |
1.842150E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.18240000013259E-08 |
| Normal-vs-N1 |
2.01709999999578E-05 |
| N0-vs-N1 |
7.618200E-02 |
|
|
